Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session ...
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
Ginkgo Bioworks Holdings, Inc. (DNA) closed at $7.63 in the latest trading session, marking a -1.55% move from the prior day.
GEN5d
Improving the Manufacture of mRNA Biologics
Production tips from Crystal Bio, TriLink Biotechnologies, Ginkgo Bioworks, Quantoom Biosciences, and Parexel.